Skip to main content
Search
Main content
Nucleic Acids Res
Published

FUS ALS-causative mutations impair FUS autoregulation and splicing factor networks through intron retention.

Authors

Jack Humphrey, Nicol Birsa, Carmelo Milioto, Martha McLaughlin, Agnieszka M Ule, David Robaldo, Andrea B Eberle, Rahel Kräuchi, Matthew Bentham, Anna-Leigh Brown, Seth Jarvis, Cristian Bodo, Maria G Garone, Anny Devoy, Gianni Soraru, Alessandro Rosa, Irene Bozzoni, Elizabeth M C Fisher, Oliver Mühlemann, Giampietro Schiavo, Marc-David Ruepp, Adrian M Isaacs, Vincent Plagnol, Pietro Fratta

Abstract

Mutations in the RNA-binding protein FUS cause amyotrophic lateral sclerosis (ALS), a devastating neurodegenerative disease. FUS plays a role in numerous aspects of RNA metabolism, including mRNA splicing. However, the impact of ALS-causative mutations on splicing has not been fully characterized, as most disease models have been based on overexpressing mutant FUS, which will alter RNA processing due to FUS autoregulation. We and others have recently created knockin models that overcome the overexpression problem, and have generated high depth RNA-sequencing on FUS mutants in parallel to FUS knockout, allowing us to compare mutation-induced changes to genuine loss of function. We find that FUS-ALS mutations induce a widespread loss of function on expression and splicing. Specifically, we find that mutant FUS directly alters intron retention levels in RNA-binding proteins. Moreover, we identify an intron retention event in FUS itself that is associated with its autoregulation. Altered FUS levels have been linked to disease, and we show here that this novel autoregulation mechanism is altered by FUS mutations. Crucially, we also observe this phenomenon in other genetic forms of ALS, including those caused by TDP-43, VCP and SOD1 mutations, supporting the concept that multiple ALS genes interact in a regulatory network.

PMID:32479602 | DOI:

UK DRI Authors

Jack Humphrey profile

Dr Jack Humphrey

Instructor at Icahn School of Medicine, Mount Sinai

Dr Jack Humphrey
Giampietro Schiavo

Prof Giampietro Schiavo

Group Leader

Restoring axonal transport deficits as a therapeutic strategy for neurodegenerative diseases

Prof Giampietro Schiavo
Image of Marc-David Ruepp

Dr Marc-David Ruepp

Group Leader

Exploring RNA metabolism in health and neurodegeneration

Dr Marc-David Ruepp
Pietro Fratta

Prof Pietro Fratta

UK DRI Co-investigator

Professor of Cellular and Molecular Neuroscience (UCL)

Prof Pietro Fratta